(Q54605226)

1 June 2018

title

Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia. (English)

1 reference

1 June 2018

1 reference

3

Rob Pieters

1 reference

1 June 2018

author name string

Vincent H J van der Velden

series ordinal

1

1 reference

1 June 2018

Patricia G Hoogeveen

series ordinal

2

1 reference

1 June 2018

Jacques J M van Dongen

series ordinal

4

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

1 June 2018

British Journal of Haematology

published in

1 reference

1 June 2018

volume

133

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

382-388

1 reference

1 June 2018

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06056.X

10.1111/J.1365-2141.2006.06056.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018